Clinical Trial

The Effects of the Female Hormones on Cerebral Perfusion

Recruiting
View on ClinicalTrials.gov →
Summary
Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey matter, resting-state brain activity, brain connectivity and white matter diffusion) caused by the female sex hormones and hormonal contraception.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-09-27; most recent amendment 2023-12-05.
Status change: Active, Not Recruiting → Recruiting 2017-10-03
Trial Details
NCT Number NCT03299179
Lead Sponsor University Ghent
Conditions Cerebral Perfusion, Contraception, Menstrual Cycle
Enrollment 62 participants
Start Date 2016-10-03
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-12-06